[HTML] springer.com

[HTML][HTML] Results and prospects of using activator of hematopoietic stem cell differentiation in complex therapy for patients with COVID-19

VK Khavinson, BI Kuznik, SV Trofimova… - Stem Cell Reviews and …, 2021 - Springer
The paper presents the results of a standard and complex treatment method using the
peptide drug thymus thymalin in patients with COVID-19. One of the mechanisms of the …
被引用次数：27 相关文章

Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19

KV Kh, BI Kuznik, SV Trofimova… - Stem Cell Reviews …, 2021 - search.proquest.com
The paper presents the results of a standard and complex treatment method using the
peptide drug thymus thymalin in patients with COVID-19. One of the mechanisms of the …
[HTML] nih.gov

[HTML][HTML] Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19

VK Khavinson, BI Kuznik, SV Trofimova… - Stem Cell Reviews …, 2021 - ncbi.nlm.nih.gov
The paper presents the results of a standard and complex treatment method using the
peptide drug thymus thymalin in patients with COVID-19. One of the mechanisms of the …

[引用][C] Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19

KV Kh - 2021 - openrepository.ru
Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex
Therapy for Patients with COVID-19 - «Национальный агрегатор открытых репозиториев …

Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19.

VK Khavinson, BI Kuznik, SV Trofimova… - Stem Cell Reviews …, 2021 - europepmc.org
The paper presents the results of a standard and complex treatment method using the
peptide drug thymus thymalin in patients with COVID-19. One of the mechanisms of the …

Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19

VK Khavinson, BI Kuznik, SV Trofimova… - Stem Cell Reviews …, 2021 - cris.bgu.ac.il
The paper presents the results of a standard and complex treatment method using the
peptide drug thymus thymalin in patients with COVID-19. One of the mechanisms of the …

Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19

VK Khavinson, BI Kuznik… - Stem cell reviews …, 2021 - pubmed.ncbi.nlm.nih.gov
The paper presents the results of a standard and complex treatment method using the
peptide drug thymus thymalin in patients with COVID-19. One of the mechanisms of the …

[引用][C] Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19

VK Khavinson, SV Trofimova, AV Trofimov… - Stem Cell Reviews and …, 2021 - elibrary.ru
RESULTS AND PROSPECTS OF USING ACTIVATOR OF HEMATOPOIETIC STEM CELL
DIFFERENTIATION IN COMPLEX THERAPY FOR PATIENTS WITH COVID-19

Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19

V Khavinson, B Kuznik, S Trofimova, V Volchkov… - 2021 - covid19.neicon.ru
The paper presents the results of a standard and complex treatment method using the
peptide drug thymus thymalin in patients with COVID-19. One of the mechanisms of the …
[PDF] neicon.ru

[PDF][PDF] Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19

VK Khavinson, BI Kuznik, SV Trofimova, VA Volchkov… - 2021 - covid19.neicon.ru
The paper presents the results of a standard and complex treatment method using the
peptide drug thymus thymalin in patients with COVID-19. One of the mechanisms of the …